Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Mechanistic Study of Subanesthetic-dose Esketamine in Modified Electroconvulsive Therapy for Adolescents With Severe Depression

NCT07247968 is registered in ClinicalTrials.gov with Min Su as lead sponsor.

NCT NCT07247968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07247968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Mechanistic Study of Subanesthetic-dose Esketamine in Modified Electroconvulsive Therapy for Adolescents With Severe Depression
Lead sponsor
Min Su
Phase
Phase 1
Overall status
Recruiting
Start date
November 25, 2025
Completion date
December 20, 2026
Enrollment
220 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adolescent, depression, ect, esketamine